Rheinfelden, Switzerland

Daniela Krummenacher

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 6.9

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • Rheinfelden, CH (2006)
  • Basel, CH (2022)

Company Filing History:


Years Active: 2006-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Daniela Krummenacher: Pioneering Inventor in the Field of Pharmaceuticals

Introduction:

Daniela Krummenacher, a trailblazing inventor based in Rheinfelden, Switzerland, is known for her unwavering passion for innovation and her relentless drive to make a positive impact on the world. With a formidable portfolio of five patents, Daniela's work continues to shape the future of technology and stands as a testament to the power of creativity and perseverance in the realm of inventions.

Latest Patents:

Daniela's latest patents include groundbreaking inventions such as Phenoxytriazoles and 4-pyrrolidino-phenyl-benzyl ether derivatives. The Phenoxytriazoles compound she developed has vast implications, particularly in the treatment of neurodegenerative diseases such as Alzheimer's disease, cerebral amyloid angiopathy, and Down syndrome. Her 4-pyrrolidino-phenyl-benzyl ether derivatives show promise in the prevention and treatment of diseases mediated by monoamine oxidase B inhibitors, including Alzheimer's disease and senile dementia.

Career Highlights:

Currently affiliated with Hoffmann-La Roche Inc., Daniela Krummenacher has made significant contributions to the pharmaceutical industry through her innovative patents. Her expertise in developing compounds with therapeutic potential has garnered recognition and acclaim within the scientific community. Her dedication to advancing medical solutions underscores her commitment to improving global healthcare outcomes.

Collaborations:

Throughout her career, Daniela has collaborated with esteemed professionals in the field, including Hans Iding and Beat Wirz. These collaborations have led to the exchange of knowledge, ideas, and expertise, further enriching the inventions and innovations she has spearheaded. By working alongside talented individuals, Daniela has been able to push the boundaries of pharmaceutical research and development, ultimately benefiting society as a whole.

Conclusion:

In conclusion, Daniela Krummenacher's pioneering spirit, coupled with her profound dedication to innovation, has established her as a leading figure in the field of pharmaceutical inventions. Her relentless pursuit of groundbreaking solutions underscores her commitment to making a positive impact on the world. As she continues to shape the landscape of technology and healthcare, Daniela's legacy as an inventive trailblazer remains a beacon of inspiration for aspiring inventors and researchers worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…